Friday, 29 April 2022

Aspirin Does Not Cut Risk in Non-Obstructive Coronary Artery Disease

Aspirin Does Not Cut Risk in Non-Obstructive Coronary Artery Disease
Aspirin Does Not Cut Risk in Non-Obstructive Coronary Artery Disease

Aspirin therapy, as opposed to statin use, for non-obstructive coronary artery disease does not reduce major cardiovascular events, according to a new study published in the journal Radiology: Cardiothoracic Imaging.

admin Fri, 04/29/2022 - 15:17

source https://www.pharmatutor.org/pharma-news/2022/aspirin-does-not-cut-risk-in-non-obstructive-coronary-artery-disease

No comments:

Post a Comment

Pharmaceutical Industry and pharma / Life Sciences institute openings 2025

  Intas Pharma Walk in Drive for M.Pharm, B.Pharm | Multiple Posts M.Pharma / B.Pharma. Injectable/Parenteral/Sterile - Aseptic, Manufacturi...